KENNETH F. BUECHLER - 22 May 2024 Form 4/A Insider Report for QuidelOrtho Corp (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Kenneth F. Buechler
Issuer symbol
QDEL
Transactions as of
22 May 2024
Net transactions value
$0
Form type
4/A
Filing time
12 Aug 2024, 20:09:44 UTC
Date Of Original Report
23 May 2024
Previous filing
14 May 2024
Next filing
29 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units (Converted) Award $0 +3,873 $0.000000 3,873 22 May 2024 Common Stock 3,873 Direct F1, F2, F3, F4
transaction QDEL Restricted Stock Units (Premium) Award $0 +1,161 $0.000000 1,161 22 May 2024 Common Stock 1,161 Direct F1, F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 originally filed on May 23, 2024 is being amended to include the grant of Converted and Premium RSUs to the reporting person on May 22, 2024.
F2 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4 968 shares vested on May 22, 2024, 968 shares will vest on August 22, 2024, 968 shares will vest on November 22, 2024 and 969 shares will vest on February 22, 2025.
F5 The restricted stock units vest on May 22, 2025.